A common respiratory or urinary tract infections increase the risk of myocardial infarction or stroke, researchers say. A study conducted by Dr. Paul Carter, a cardiologist at the Aston Medical School in the UK, examined more than 34,000 people admitted to hospitals with respiratory or urinary tract infections which were kept under observation for 14 years and compared with a control group with the same age, sex.
People suffering from respiratory and/or urinary tract infections has 3 times higher risks to die from myocardial infarction
The group suffering from respiratory and urinary tract infections showed by 40% higher risks of suffering a myocardial infarction during this period compared to the control group and by 150% higher risks of having a stroke, according to Carter.
In the group suffering from respiratory and urinary tract infections, the risk of death from myocardial infarction was three times higher than that of the control group, and the risk of death from strokes was two times higher than that of the control group.
The results show that there is a clear link between infections and myocardial infarction and strokes and that the importance of this association is high, as Dr. Carter explained.
This study is part of a larger studies collection conducted to prove or debunk the Canakinumab anti-inflammatory drug
“It can be interpreted that infection has a greater impact than obesity, which increases the risk of myocardial infarction and stroke by 25%, and is similar to hypertension and diabetes,” Carter said.
Scientists are paying close attention to the effects of infections and inflammation on cardiac and brain health after a study published last year suggests that Canakinumab, an anti-inflammatory drug developed by Novartis, reduces the risk of myocardial infarction by 24%.
The study concluded that respiratory and urinary tract infections increase the risk of myocardial infections and stroke. The researchers presented the results at the 67th annual conference of the American College of Cardiology which has been held between March 10-12, in Orlando, in the USA.